Business · 23/08/2021Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Review and Clearance
Summary
The Food and Drug Administration (FDA) is announcing a proposed collection of information for review and clearance under the Paperwork Reduction Act of 1995, related to human drug compounding, repackaging, and activities regarding sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →